Ken Griffin En V Veno Medical Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in En V Veno Medical Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 13,900 shares of NVNO stock, worth $47,538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,900
Previous 35,400
60.73%
Holding current value
$47,538
Previous $104,000
65.38%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NVNO
# of Institutions
36Shares Held
4.05MCall Options Held
34.1KPut Options Held
2.5K-
Kingdon Capital Management, L.L.C. New York, NY859KShares$2.94 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA601KShares$2.06 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$2.03 Million0.07% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$1.37 Million3.48% of portfolio
-
Ubs Oconnor LLC Chicago, IL296KShares$1.01 Million0.05% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $32.4M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...